Q2 2025 · 13F-HR
Knott David M Jrholdings as filed
Filed 2025-08-11 · accession 0001104659-25-076007
$220.6M
Reported value
85
Positions
2025-06-30
Period end
The Brief · Knott David M Jr · Q2 2025
AI · grounded in 13F
Knott David M Jr established a new position in Calumet, Inc. CLMT valued at $51.6M. The fund also initiated new stakes in Apollo Global Management, Inc. APO for $31.9M and Janus Henderson AAA CLO ETF JAAA for $25.1M. Additional new positions include Alphabet Inc-Cl C GOOG at $19.9M and JPMorgan Chase & Co. JPM at $6.1M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 131428104 | CLMT | Calumet, Inc. | $51.6M | 23.4% | 3,275,231 | Common | SOLE |
| 03769M106 | APO | Apollo Global Management, Inc. | $31.9M | 14.5% | 225,000 | Common | SOLE |
| 47103U845 | JAAA | Janus Henderson AAA CLO ETF | $25.1M | 11.4% | 495,254 | Common | SOLE |
| 02079K107 | GOOG | Alphabet Inc-Cl C | $19.9M | 9.02% | 112,220 | Common | SOLE |
| 46625H100 | JPM | JPMorgan Chase & Co. | $6.1M | 2.76% | 20,985 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma PLC. | $5.2M | 2.36% | 55,000 | Common | SOLE |
| 98422E103 | XERS | Xeris Biopharma Holdings, Inc. | $5.0M | 2.24% | 1,060,000 | Common | SOLE |
| 256086109 | DCGO | DocGo, Inc. | $4.8M | 2.19% | 3,070,850 | Common | SOLE |
| 74366E102 | PTGX | Protagonist Therapeutics, Inc | $4.4M | 2.00% | 80,000 | Common | SOLE |
| 89422G107 | TVTX | Travere Therapeutics, Inc. | $3.8M | 1.74% | 260,000 | Common | SOLE |
| 14888U101 | CPRX | Catalyst Pharmaceuticals, Inc. | $3.8M | 1.73% | 176,000 | Common | SOLE |
| G29687103 | AVDL | Avadel Pharmaceuticals plc | $3.8M | 1.71% | 426,000 | Common | SOLE |
| 10806X102 | BBIO | Bridgebio Pharma, Inc. | $3.5M | 1.57% | 80,000 | Common | SOLE |
| 87164F105 | SNDX | Syndax Pharmaceutical, Inc. | $3.3M | 1.50% | 352,778 | Common | SOLE |
| 09058V103 | BCRX | BioCryst Pharmaceuticals, Inc. | $3.0M | 1.35% | 332,625 | Common | SOLE |
| 45790W108 | — | Inozyme Pharma, Inc. | $2.7M | 1.21% | 666,204 | Common | SOLE |
| G3075P101 | ESGRUSD | Enstar Group Limited | $2.5M | 1.14% | 7,500 | Common | SOLE |
| 52635N103 | LENZ | LENZ Therapeutics, Inc. | $2.4M | 1.09% | 82,000 | Common | SOLE |
| 126408103 | CSX | CSX Corporation | $2.3M | 1.04% | 70,000 | Common | SOLE |
| 01881G106 | AB | AllianceBernstein Holding L.P. | $2.0M | 0.89% | 48,000 | Common | SOLE |
| 90400D108 | RARE | Ultragenyx Pharmaceutical Inc. | $1.9M | 0.86% | 52,000 | Common | SOLE |
| 717081103 | PFE | Pfizer Inc. | $1.8M | 0.82% | 74,537 | Common | SOLE |
| 03940C100 | ACLXGBX | Arcellx Inc | $1.7M | 0.77% | 25,700 | Common | SOLE |
| 04963C209 | ATRC | AtriCure, Inc. | $1.5M | 0.69% | 46,443 | Common | SOLE |
| 878972108 | TECX | Tectonic Therapeutic, Inc. | $1.5M | 0.67% | 74,000 | Common | SOLE |
| G01767105 | ALKS | Alkermes PLC | $1.4M | 0.64% | 49,000 | Common | SOLE |
| 92790C104 | VRDN | Viridian Therapeutics, Inc. | $1.3M | 0.58% | 91,483 | Common | SOLE |
| 81752T528 | CLOZ | The Panagram BBB-B CLO ETF | $1.3M | 0.58% | 47,807 | Common | SOLE |
| 110122108 | BMY | Bristol-Myers Squibb Company | $1.2M | 0.57% | 27,000 | Common | SOLE |
| 78377T107 | RHP | Ryman Hospitality Properties, Inc. | $1.2M | 0.54% | 12,000 | Common | SOLE |
| 53635D202 | LQDA | Liquidia Corporation | $1.1M | 0.51% | 90,000 | Common | SOLE |
| 478160104 | JNJ | Johnson & Johnson | $1.1M | 0.48% | 6,922 | Common | SOLE |
| 62855J104 | MYGN | Myriad Genetics, Inc. | $955,800 | 0.43% | 180,000 | Common | SOLE |
| 00287Y109 | ABBV | AbbVie Inc. | $934,968 | 0.42% | 5,037 | Common | SOLE |
| 589492107 | MREO | Mereo BioPharm Group PLC | $865,403 | 0.39% | 319,337 | Common | SOLE |
| 22052L104 | CTVA | Corteva, Inc. | $823,631 | 0.37% | 11,051 | Common | SOLE |
| 594918104 | MSFT | Microsoft Corporation | $795,856 | 0.36% | 1,600 | Common | SOLE |
| 83422E204 | SLDB | Solid Bioscience Inc. | $791,083 | 0.36% | 162,440 | Common | SOLE |
| 494368103 | KMB | Kimberly-Clark Corporation | $773,520 | 0.35% | 6,000 | Common | SOLE |
| 19459J104 | COLL | Collegium Pharmaceutical, Inc. | $695,220 | 0.32% | 23,511 | Common | SOLE |
| 26614N102 | DD | DuPont de Nemours, Inc. | $645,981 | 0.29% | 9,418 | Common | SOLE |
| 459200101 | IBM | International Business Machines | $631,419 | 0.29% | 2,142 | Common | SOLE |
| 05464T104 | AXSM | Axsome Therapeutics, Inc. | $626,340 | 0.28% | 6,000 | Common | SOLE |
| 05280R100 | AUTL | Autolus Therapeutics PLC | $615,600 | 0.28% | 270,000 | Common | SOLE |
| 50075N104 | — | Mondelez International Inc. | $606,960 | 0.28% | 9,000 | Common | SOLE |
| 558868105 | MDGL | Madrigal Pharmaaceuticals, Inc. | $605,280 | 0.27% | 2,000 | Common | SOLE |
| 03969F109 | RCUS | Arcus Biosciences, Inc. | $569,800 | 0.26% | 70,000 | Common | SOLE |
| 23256X407 | HELP | Cybin Inc | $561,123 | 0.25% | 66,880 | Common | SOLE |
| 136385101 | CNQ | Canadian Natural Resources Limited | $527,520 | 0.24% | 16,800 | Common | SOLE |
| 037833100 | AAPL | Apple Inc. | $511,694 | 0.23% | 2,494 | Common | SOLE |
| 92337R101 | VERA | Vera Therapeutics, Inc. | $471,200 | 0.21% | 20,000 | Common | SOLE |
| 98420N105 | XENE | Xenon Pharmaceuticals Inc. | $343,111 | 0.16% | 10,962 | Common | SOLE |
| 68572M106 | OBIO | Orchestra Biomed Holdings, Inc. | $268,000 | 0.12% | 100,000 | Common | SOLE |
| Y95308105 | WVE | Wave Life Science Ltd. | $260,000 | 0.12% | 40,000 | Common | SOLE |
| 002120202 | ATYR | aTyr Pharma, Inc. | $255,361 | 0.12% | 50,367 | Common | SOLE |
| 464287556 | IBB | iShares Nasdaq Biotechnology ETF | $253,020 | 0.11% | 2,000 | Common | SOLE |
| 78464A870 | XBI | SPDR S&P Biotech ETF | $248,790 | 0.11% | 3,000 | Common | SOLE |
| 532457108 | LLY | Eli Lilly & Co. | $233,859 | 0.11% | 300 | Common | SOLE |
| 23954D109 | DAWNGBX | Day One Biopharmaceuticals, Inc. | $219,141 | 0.10% | 33,714 | Common | SOLE |
| 67066G104 | NVDA | Nvidia Corp | $202,227 | 0.09% | 1,280 | Common | SOLE |
| 11135F101 | AVGO | Broadcom, Inc. | $195,711 | 0.09% | 710 | Common | SOLE |
| 191216100 | KO | Coca-Cola Co. | $141,500 | 0.06% | 2,000 | Common | SOLE |
| 464287481 | IWP | iShares Russell Mid-Cap Growth | $96,383 | 0.04% | 695 | Common | SOLE |
| 52472M101 | LEGH | Legacy Housing Corporation | $90,640 | 0.04% | 4,000 | Common | SOLE |
| 27627N105 | EBC | Eastern Bankshares Inc | $76,350 | 0.03% | 5,000 | Common | SOLE |
| 89151E109 | TTEN | TotalEnergies SE - ADR | $73,668 | 0.03% | 1,200 | Common | SOLE |
| 74762E102 | QURE | Quanta Services, Inc. | $66,542 | 0.03% | 176 | Common | SOLE |
| 023135106 | AMZN | Amazon.com Inc. | $65,817 | 0.03% | 300 | Common | SOLE |
| 302635206 | FSK | FS KKR Capital Corp. | $59,656 | 0.03% | 2,875 | Common | SOLE |
| 911363109 | URI | United Rental, Inc. | $58,765 | 0.03% | 78 | Common | SOLE |
| 30263Y104 | FSBW | FS Bancorp, Inc. | $57,495 | 0.03% | 1,460 | Common | SOLE |
| 02079k305 | — | Alphabet Inc CL A | $52,869 | 0.02% | 300 | Common | SOLE |
| G4863A108 | BRSL | International Game Technology PLC | $39,525 | 0.02% | 2,500 | Common | SOLE |
| 235851102 | DHR | Danaher Corporation | $35,557 | 0.02% | 180 | Common | SOLE |
| 260557103 | DOW | Dow Inc. | $31,935 | 0.01% | 1,206 | Common | SOLE |
| 09260d107 | — | Blackstone Group LP | $31,412 | 0.01% | 210 | Common | SOLE |
| 674599105 | OXY | Occidential Pertro Wts exp. 8/3/27 | $23,971 | 0.01% | 663 | Common | SOLE |
| 00208D408 | AETUF | Arc Resources Ltd. | $23,401 | 0.01% | 1,110 | Common | SOLE |
| 79466L302 | CRM | Salesforce, Inc. | $20,997 | 0.01% | 77 | Common | SOLE |
| 883556102 | TMO | Thermo Fisher Scientific, Inc. | $18,246 | 0.01% | 45 | Common | SOLE |
| 50155Q100 | KD | Kyndryl Holdings Inc. | $17,959 | 0.01% | 428 | Common | SOLE |
| 91324p102 | — | United Healthcare Corp. | $17,782 | 0.01% | 57 | Common | SOLE |
| 85571B105 | STWD | Starwood Property Trust, Inc. | $8,028 | 0.00% | 400 | Common | SOLE |
| 36266G107 | GEHC | GE HealthCare Technologies Inc | $3,703 | 0.00% | 50 | Common | SOLE |
| 929740108 | WAB | Wabtec Corporation | $1,256 | 0.00% | 6 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.